financetom
Business
financetom
/
Business
/
Maze Therapeutics targets to raise up to $133 mln in US IPO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Maze Therapeutics targets to raise up to $133 mln in US IPO
Jan 27, 2025 3:28 AM

Jan 27 (Reuters) - Drug developer Maze Therapeutics said

on Monday it was aiming to raise as much as $132.6 million in

its initial public offering in the United States.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Jose Andres, the celebrity chef sidestepping bureaucracy to bring aid to Gaza
Jose Andres, the celebrity chef sidestepping bureaucracy to bring aid to Gaza
Apr 2, 2024
MADRID, April 2 (Reuters) - Celebrity chef Jose Andres' disdain for red tape is one of the reasons why his food charity found itself coordinating the humanitarian effort in Gaza when seven of its workers were killed in an Israeli airstrike. The aid workers for World Central Kitchen (WCK) were killed when their convoy was hit shortly after overseeing the...
Canoo Remains Cost Conscious Amid Capital Concerns, Wedbush Says
Canoo Remains Cost Conscious Amid Capital Concerns, Wedbush Says
Apr 2, 2024
01:40 PM EDT, 04/02/2024 (MT Newswires) -- Canoo ( GOEV ) has remained cost conscious amid concerns over its capital needs after the electric vehicles maker missed revenue expectations while beating consensus on the bottom line in Q4, Wedbush said in a report Tuesday. From a cost perspective, the company remains extremely cost conscious, lowering its overall R&D expense by...
Simply Better Brands Provides Corporate Update, Suspends Operations of Purekana Subsidiary
Simply Better Brands Provides Corporate Update, Suspends Operations of Purekana Subsidiary
Apr 2, 2024
01:39 PM EDT, 04/02/2024 (MT Newswires) -- Simply Better Brands ( SBBCF ) shares were last seen up 7.2% after the company on Tuesday said operations of its 50.1% owned subsidiary, PureKana, LLC, are being suspended. According to a company statement, PureKana plans to commence bankruptcy proceedings under Chapter 7 of the Bankruptcy Code of the United States as soon...
Telo Genomics' MRD Clinical Trial Expands into Multi-Center Trial; Shares up 9.5%
Telo Genomics' MRD Clinical Trial Expands into Multi-Center Trial; Shares up 9.5%
Apr 2, 2024
01:42 PM EDT, 04/02/2024 (MT Newswires) -- Telo Genomics ( TDSGF ) a biotech company developing a telomere technology platform with applications measuring genomic instability in oncology, reports that patient recruitment for its minimal residual disease (MRD) clinical trial have begun. MRD refers to cancer cells that remain in the patient's system post-treatment. So far, several patient samples have been...
Copyright 2023-2026 - www.financetom.com All Rights Reserved